156 related articles for article (PubMed ID: 38697991)
1. Response of treatment-naive brain metastases to stereotactic radiosurgery.
Ene CI; Abi Faraj C; Beckham TH; Weinberg JS; Andersen CR; Haider AS; Rao G; Ferguson SD; Alvarez-Brenkenridge CA; Kim BYS; Heimberger AB; McCutcheon IE; Prabhu SS; Wang CM; Ghia AJ; McGovern SL; Chung C; McAleer MF; Tom MC; Perni S; Swanson TA; Yeboa DN; Briere TM; Huse JT; Fuller GN; Lang FF; Li J; Suki D; Sawaya RE
Nat Commun; 2024 May; 15(1):3728. PubMed ID: 38697991
[TBL] [Abstract][Full Text] [Related]
2. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
5. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
6. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
7. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
8. Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases.
Koffer P; Chan J; Rava P; Gorovets D; Ebner D; Savir G; Kinsella T; Cielo D; Hepel JT
World Neurosurg; 2017 Aug; 104():589-593. PubMed ID: 28450235
[TBL] [Abstract][Full Text] [Related]
9. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?
Chang WS; Kim HY; Chang JW; Park YG; Chang JH
J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789
[TBL] [Abstract][Full Text] [Related]
10. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
[TBL] [Abstract][Full Text] [Related]
11. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
Brennan C; Yang TJ; Hilden P; Zhang Z; Chan K; Yamada Y; Chan TA; Lymberis SC; Narayana A; Tabar V; Gutin PH; Ballangrud Å; Lis E; Beal K
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):130-6. PubMed ID: 24331659
[TBL] [Abstract][Full Text] [Related]
12. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
13. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
16. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
[TBL] [Abstract][Full Text] [Related]
18. Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy.
Pessina F; Navarria P; Tomatis S; Cozzi L; Franzese C; Di Guardo L; Ascolese AM; Reggiori G; Franceschini D; Del Vecchio M; Bello L; Scorsetti M
World Neurosurg; 2017 Sep; 105():184-190. PubMed ID: 28578123
[TBL] [Abstract][Full Text] [Related]
19. Response of intracranial melanoma metastases to stereotactic radiosurgery.
Gieger M; Wu JK; Ling MN; Wazer D; Tsai JS; Engler MJ
Radiat Oncol Investig; 1997; 5(2):72-80. PubMed ID: 9303060
[TBL] [Abstract][Full Text] [Related]
20. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
